Pilot phase I study of gefitinib (GEF) in combination with paclitaxel (PAC) and radiation therapy (RT) in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) and effects on epidermal growth factor receptor (EGFR) signaling pathway

被引：0
|
作者：
Morris, J. C.
Allen, C.
Citrin, D.
Gius, D.
Chen, Z.
Colevas, A. D.
Harold, N.
Rudy, S.
Singh, A. K.
VanWaes, C.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] NIDCD, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16526
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma - A phase I study
    Fuwa, N
    Ito, Y
    Matsumoto, A
    Kamata, M
    Kodaira, T
    Furutani, K
    Sasaoka, M
    Kimura, Y
    Morita, K
    CANCER, 2000, 89 (10) : 2099 - 2105
  • [42] A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma
    Grégoire, V
    Ang, KK
    Rosier, JF
    Beauduin, M
    Garden, AS
    Hamoir, M
    Hittelman, WN
    Humblet, Y
    Khuri, FR
    Milas, L
    Mitine, C
    Scalliet, P
    RADIOTHERAPY AND ONCOLOGY, 2002, 63 (02) : 187 - 193
  • [43] Dual inhibition of the epidermal growth factor receptor (EGFR) pathway with the combination of cetuximab and erlotinib: A phase I study in patients with advanced solid malignancies
    Guarino, Michael J.
    Schneider, Charles J.
    Hosford, Martha A.
    Brahmer, Julie R.
    Rudin, Charles M.
    Finckenstein, Friedrich Graf
    Philip-Norton, Robyn E.
    Lu, Haolan
    Weber, Martin R.
    Ettinger, David S.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3383S - 3383S
  • [44] Prospective multicenter phase II study of the anti- EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre- treated, advanced head and neck squamous cell cancer (HNSCC)
    Siano, M.
    Molinari, F.
    Martin, V.
    Mach, N.
    Frueh, M.
    Crippa, S.
    Ghielmini, M.
    Frattini, M.
    Espeli, V.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S576 - S577
  • [45] Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC)
    Siano, M.
    Molinari, F.
    Martin, V.
    Mach, N.
    Frueh, M.
    Crippa, S.
    Ghielmini, M.
    Frattini, M.
    Espeli, V.
    Oncology Research and Treatment, 2015, 38 : 25 - 25
  • [46] Phase I study of epidermal growth factor receptor (EGFR) inhibitor, erlotinib, and vascular endothelial growth factor monoclonal antibody, bevacizumab, in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
    Mauer, AM
    Cohen, EEW
    Wong, SJ
    Kozloff, M
    Winegarden, J
    Gustin, DM
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 497S - 497S
  • [47] Multicenter phase II trial of nab-paclitaxel and cisplatin (AP) followed by chemoradiation therapy (CRT) for locally advanced head and neck squamous cell carcinoma (HNSCC)
    Adkins, D.
    Ley, J.
    Gay, H. A.
    Daly, M.
    Jackson, R.
    Rich, J.
    Pipkorn, P.
    Paniello, R. C.
    Trinkaus, K.
    Neupane, P.
    Zevallos, J.
    Thorstad, W.
    Oppelt, P.
    ANNALS OF ONCOLOGY, 2018, 29 : 381 - 381
  • [48] Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck
    Haddad, R
    Posner, M
    CANCER, 2003, 97 (06) : 1589 - 1589
  • [49] A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC).
    Dunn, Lara
    Sherman, Eric Jeffrey
    Ho, Alan Loh
    Ganly, Ian
    Riaz, Nadeem
    Morris, Luc
    Hung, Kin Wai
    Kriplani, Anuja
    Cracchiolo, Jennifer R.
    Cohen, Marc
    Boyle, Jay
    Patel, Snehal G.
    Haque, Sofia
    Katabi, Nora
    Ghossein, Ronald A.
    McBride, Sean Matthew
    Michel, Loren S.
    Wong, Richard J.
    Lee, Nancy Y.
    Pfister, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck
    Shin, DM
    Glisson, BS
    Khuri, FR
    Lippman, SM
    Ginsberg, L
    Diaz, E
    Papadimitrakopoulou, V
    Feng, L
    Francisco, M
    Garden, A
    Kies, MS
    Myers, J
    Clayman, G
    Hong, WK
    CANCER, 2002, 95 (02) : 322 - 330
12345